Jazz Pharmaceuticals
JAZZ
#2147
Rank
NZ$11.94 B
Marketcap
$196.61
Share price
-8.92%
Change (1 day)
2.64%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$2.13

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.52. In 2022 the company made an earnings per share (EPS) of -$6.32 an increase over its 2021 EPS that were of -$9.61.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.13-66.3%
2022-$6.32-34.2%
2021-$9.61-224.83%
2020$7.70-53.25%
2019$16.4723.59%
2018$13.33-8.24%
2017$14.5323.74%
2016$11.7422.12%
2015$9.61478.49%
2014$1.66-74.93%
2013$6.63-27.11%
2012$9.0969.1%
2011$5.38245.98%
2010$1.55-462.5%
2009-$0.43-96.7%
2008-$13.01-27.04%
2007-$17.8365.47%
2006-$10.77-4.59%
2005-$11.29

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$7.18 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$14.81-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.68-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$3.57 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel